Rocket Pharmaceuticals: Reprioritization Key To Milestone Achievement By 2026
Source: SeekingAlpha
2025-08-15 03:45:51 ET
...
Read the full article on Seeking Alpha
For further details see:
Rocket Pharmaceuticals: Reprioritization Key To Milestone Achievement By 2026
Rocket Pharmaceuticals Inc. Warrant
NASDAQ: RCKTW
RCKTW Trading
11.61% G/L:
$0.0173 Last:
5,750 Volume:
$0.017499 Open:
RCKTW Latest News
RCKTW Stock Data
$346,311,130
77,378,893
N/A
48
N/A
Biotechnology & Life Sciences
Healthcare
US
Cranbury
